Habermann TM - Search Results

1

Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494).

Morrison VA, Weller EA, Habermann TM, Li S, Fisher RI, Cheson BD, Peterson BA. Morrison VA, et al. Among authors: habermann tm. Leuk Lymphoma. 2017 Aug;58(8):1814-1822. doi: 10.1080/10428194.2016.1265111. Epub 2016 Dec 14. Leuk Lymphoma. 2017. PMID: 27967294 Free PMC article. Clinical Trial.

2

Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin's lymphoma.

Colgan JP, Andersen J, Habermann TM, Earle JD, O'Connell MJ, Neiman RS, Mann RB, Glick JH. Colgan JP, et al. Among authors: habermann tm. Leuk Lymphoma. 1994 Oct;15(3-4):291-6. doi: 10.3109/10428199409049726. Leuk Lymphoma. 1994. PMID: 7866277 Clinical Trial.

3

Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma.

Ansell SM, Habermann TM, Kurtin PJ, Witzig TE, Chen MG, Li CY, Inwards DJ, Colgan JP. Ansell SM, et al. Among authors: habermann tm. J Clin Oncol. 1997 Jun;15(6):2296-301. doi: 10.1200/JCO.1997.15.6.2296. J Clin Oncol. 1997. PMID: 9196143

4

A phase I trial of high dose ProMACE-CytaBOM with granulocyte colony stimulating factor for patients with non-Hodgkin's lymphoma.

Witzig TE, Camoriano JK, Schroeder G, Kurtin PJ, Habermann TM. Witzig TE, et al. Among authors: habermann tm. Leuk Lymphoma. 1998 Jan;28(3-4):307-14. doi: 10.3109/10428199809092686. Leuk Lymphoma. 1998. PMID: 9517502 Clinical Trial.

5

Primary thyroid lymphoma.

Ansell SM, Grant CS, Habermann TM. Ansell SM, et al. Among authors: habermann tm. Semin Oncol. 1999 Jun;26(3):316-23. Semin Oncol. 1999. PMID: 10375088 Review.

6

Evaluation of the proliferative index as a prognostic factor in diffuse large cell lymphoma: correlation with the International Index.

Ansell SM, Kurtin PJ, Stenson M, Habermann TM, Greipp PR, Therneau TM, Witzig TE. Ansell SM, et al. Among authors: habermann tm. Leuk Lymphoma. 1999 Aug;34(5-6):529-37. doi: 10.3109/10428199909058480. Leuk Lymphoma. 1999. PMID: 10492076

7

A phase II trial of 200% ProMACE-CytaBOM in patients with previously untreated aggressive lymphomas: analysis of response, toxicity, and dose intensity.

Gordon LI, Young M, Weller E, Habermann TM, Winter JN, Glick J, Ghosh C, Flynn P, Cassileth PA. Gordon LI, et al. Among authors: habermann tm. Blood. 1999 Nov 15;94(10):3307-14. Blood. 1999. PMID: 10552939 Free article. Clinical Trial.

8

Non-Hodgkin's lymphoma: present status and future prospects.

Habermann TM. Habermann TM. Hosp Pract (1995). 1999 Dec 15;34(13):81-4, 87-8. doi: 10.3810/hp.1999.12.178. Hosp Pract (1995). 1999. PMID: 10611900

9

Smoking and risk of non-Hodgkin lymphoma subtypes in a cohort of older women.

Parker AS, Cerhan JR, Dick F, Kemp J, Habermann TM, Wallace RB, Sellers TA, Folsom AR. Parker AS, et al. Among authors: habermann tm. Leuk Lymphoma. 2000 Apr;37(3-4):341-9. doi: 10.3109/10428190009089434. Leuk Lymphoma. 2000. PMID: 10752985

10

Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome.

Ansell SM, Stenson M, Habermann TM, Jelinek DF, Witzig TE. Ansell SM, et al. Among authors: habermann tm. J Clin Oncol. 2001 Feb 1;19(3):720-6. doi: 10.1200/JCO.2001.19.3.720. J Clin Oncol. 2001. PMID: 11157023

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

452 results

Search Page